RT Journal Article
T1 Management of anaphylaxis due to COVID-19 vaccines in the elderly.
A1 Bousquet, Jean
A1 Agache, Ioana
A1 Blain, Hubert
A1 Jutel, Marek
A1 Ventura, Maria Teresa
A1 Worm, Margitta
A1 Del Giacco, Stefano
A1 Benetos, Athanasios
A1 Bilo, Beatrice Maria
A1 Czarlewski, Wienczyslawa
A1 Abdul Latiff, Amir Hamzah
A1 Al-Ahmad, Mona
A1 Angier, Elizabeth
A1 Annesi-Maesano, Isabella
A1 Atanaskovic-Markovic, Marina
A1 Bachert, Claus
A1 Barbaud, Annick
A1 Bedbrook, Anna
A1 Bennoor, Kazi S
A1 Berghea, Elena Camelia
A1 Bindslev-Jensen, Carsten
A1 Bonini, Sergio
A1 Bosnic-Anticevich, Sinthia
A1 Brockow, Knut
A1 Brussino, Luisa
A1 Camargos, Paulo
A1 Canonica, G Walter
A1 Cardona, Victoria
A1 Carreiro-Martins, Pedro
A1 Carriazo, Ana
A1 Casale, Thomas
A1 Caubet, Jean-Christoph
A1 Cecchi, Lorenzo
A1 Cherubini, Antonio
A1 Christoff, George
A1 Chu, Derek K
A1 Cruz, Alvaro A
A1 Dokic, Dejan
A1 El-Gamal, Yehia
A1 Ebisawa, Motohiro
A1 Eberlein, Bernadette
A1 Farrell, John
A1 Fernandez-Rivas, Montserrat
A1 Fokkens, Wytske J
A1 Fonseca, Joao A
A1 Gao, Yadong
A1 Gavazzi, Gaëtan
A1 Gawlik, Radoslaw
A1 Gelincik, Asli
A1 Gemicioğlu, Bilun
A1 Gotua, Maia
A1 Guérin, Olivier
A1 Haahtela, Tari
A1 Hoffmann-Sommergruber, Karin
A1 Hoffmann, Hans Jürgen
A1 Hofmann, Maja
A1 Hrubisko, Martin
A1 Illario, Maddalena
A1 Irani, Carla
A1 Ispayeva, Zhanat
A1 Ivancevich, Juan Carlos
A1 Julge, Kaja
A1 Kaidashev, Igor
A1 Khaitov, Musa
A1 Knol, Edward
A1 Kraxner, Helga
A1 Kuna, Piotr
A1 Kvedariene, Violeta
A1 Lauerma, Antti
A1 Le, Lan T T
A1 Le Moing, Vincent
A1 Levin, Michael
A1 Louis, Renaud
A1 Lourenco, Olga
A1 Mahler, Vera
A1 Martin, Finbarr C
A1 Matucci, Andrea
A1 Milenkovic, Branislava
A1 Miot, Stéphanie
A1 Montella, Emma
A1 Morais-Almeida, Mario
A1 Mortz, Charlotte G
A1 Mullol, Joaquim
A1 Namazova-Baranova, Leyla
A1 Neffen, Hugo
A1 Nekam, Kristof
A1 Niedoszytko, Marek
A1 Odemyr, Mikaëla
A1 O'Hehir, Robyn E
A1 Okamoto, Yoshitaka
A1 Ollert, Markus
A1 Palomares, Oscar
A1 Papadopoulos, Nikolaos G
A1 Panzner, Petr
A1 Passalacqua, Giovanni
A1 Patella, Vincenzo
A1 Petrovic, Mirko
A1 Pfaar, Oliver
A1 Pham-Thi, Nhân
A1 Plavec, Davor
A1 Popov, Todor A
A1 Recto, Marysia T
A1 Regateiro, Frederico S
A1 Reynes, Jacques
A1 Roller-Winsberger, Regina E
A1 Rolland, Yves
A1 Romano, Antonino
A1 Rondon, Carmen
A1 Rottem, Menachem
A1 Rouadi, Philip W
A1 Salles, Nathalie
A1 Samolinski, Boleslaw
A1 Santos, Alexandra F
A1 S Sarquis, Faradiba
A1 Sastre, Joaquin
A1 M G A Schols, Jos
A1 Scichilone, Nicola
A1 Sediva, Anna
A1 Shamji, Mohamed H
A1 Sheikh, Aziz
A1 Skypala, Isabel
A1 Smolinska, Sylwia
A1 Sokolowska, Milena
A1 Sousa-Pinto, Bernardo
A1 Sova, Milan
A1 Stelmach, Rafael
A1 Sturm, Gunter
A1 Suppli Ulrik, Charlotte
A1 Todo-Bom, Ana Maria
A1 Toppila-Salmi, Sanna
A1 Tsiligianni, Ioanna
A1 Torres, Maria
A1 Untersmayr, Eva
A1 Urrutia Pereira, Marilyn
A1 Valiulis, Arunas
A1 Vitte, Joana
A1 Vultaggio, Alessandra
A1 Wallace, Dana
A1 Walusiak-Skorupa, Jolanta
A1 Wang, De-Yun
A1 Waserman, Susan
A1 Yorgancioglu, Arzu
A1 Yusuf, Osman M
A1 Zernotti, Mario
A1 Zidarn, Mihaela
A1 Chivato, Tomas
A1 Akdis, Cezmi A
A1 Zuberbier, Torsten
A1 Klimek, Ludger
K1 COVID-19 vaccines
K1 adrenaline
K1 anaphylaxis
K1 older (adults/people)
AB Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritized to receive COVID-19 vaccines due to high risk of death. In very rare instances, the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society) Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients.
YR 2021
FD 2021
LK https://hdl.handle.net/10668/24539
UL https://hdl.handle.net/10668/24539
LA en
DS RISalud
RD Jul 17, 2025